These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
52. MicroRNA214 Is Associated With Progression of Ulcerative Colitis, and Inhibition Reduces Development of Colitis and Colitis-Associated Cancer in Mice. Polytarchou C; Hommes DW; Palumbo T; Hatziapostolou M; Koutsioumpa M; Koukos G; van der Meulen-de Jong AE; Oikonomopoulos A; van Deen WK; Vorvis C; Serebrennikova OB; Birli E; Choi J; Chang L; Anton PA; Tsichlis PN; Pothoulakis C; Verspaget HW; Iliopoulos D Gastroenterology; 2015 Oct; 149(4):981-92.e11. PubMed ID: 26055138 [TBL] [Abstract][Full Text] [Related]
53. Platelet density and size in inflammatory bowel disease. Järemo P; Sandberg-Gertzen H Thromb Haemost; 1996 Apr; 75(4):560-1. PubMed ID: 8743178 [TBL] [Abstract][Full Text] [Related]
54. Zinc Deficiency is Associated with Poor Clinical Outcomes in Patients with Inflammatory Bowel Disease. Siva S; Rubin DT; Gulotta G; Wroblewski K; Pekow J Inflamm Bowel Dis; 2017 Jan; 23(1):152-157. PubMed ID: 27930412 [TBL] [Abstract][Full Text] [Related]
55. Evidence for a novel serum factor distinct from zinc alpha-2 glycoprotein that promotes body fat loss early in the development of cachexia. Byerley LO; Lee SH; Redmann S; Culberson C; Clemens M; Lively MO Nutr Cancer; 2010; 62(4):484-94. PubMed ID: 20432169 [TBL] [Abstract][Full Text] [Related]
56. Diagnostic value of serum procalcitonin in determining the activity of inflammatory bowel disease. Oruç N; Ozütemiz O; Osmanoğlu N; Ilter T Turk J Gastroenterol; 2009 Mar; 20(1):9-12. PubMed ID: 19330729 [TBL] [Abstract][Full Text] [Related]
57. Circulating von Willebrand factor in inflammatory bowel disease. Stevens TR; James JP; Simmonds NJ; McCarthy DA; Laurenson IF; Maddison PJ; Rampton DS Gut; 1992 Apr; 33(4):502-6. PubMed ID: 1582595 [TBL] [Abstract][Full Text] [Related]
58. Role of soluble triggering receptor expressed on myeloid cells in inflammatory bowel disease. Tzivras M; Koussoulas V; Giamarellos-Bourboulis EJ; Tzivras D; Tsaganos T; Koutoukas P; Giamarellou H; Archimandritis A World J Gastroenterol; 2006 Jun; 12(21):3416-9. PubMed ID: 16733861 [TBL] [Abstract][Full Text] [Related]
59. Circulating D dimer in inflammatory bowel disease. Biancone L; Scopinaro F; Maletta M; Monteleone G; Luzza F; Banci M; Mercantini P; Renda T; Pallone F Ital J Gastroenterol; 1994 Apr; 26(3):116-20. PubMed ID: 8061337 [TBL] [Abstract][Full Text] [Related]
60. Circulating antioxidant concentrations in children with inflammatory bowel disease. Hoffenberg EJ; Deutsch J; Smith S; Sokol RJ Am J Clin Nutr; 1997 May; 65(5):1482-8. PubMed ID: 9129480 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]